Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum WELL Health Technologies Corp T.WELL

Alternate Symbol(s):  WHTCF | T.WELL.DB

WELL Health Technologies Corp. is a Canada-based practitioner-focused digital healthcare company. Its healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. Its business units include Canadian Patient Services, WELL Health USA Patient and Provider Services, and SaaS and Technology Services... see more

TSX:WELL - Post Discussion

View:
Post by speedy99 on Jun 30, 2022 8:07am

set to rebound

Well Health Technologies stock is set to rebound as profitability nears

By: Crispus Nyaga
on Jun 30, 2022
  • Well Health Technologies is a rapidly growing telehealth company.
  • It has operations in Canada and the US and is seeing strong revenue growth.
  • Well recently released a set of ESG commitments that are expected to drive benefits for shareholders.

Well Health Technologies (TSX: WELL) has outperformed other telehealth companies in the telehealth industry in 2020. While competitors like Doximity, Hims & Hers, and Teladoc have been hit badly, Well has fared significantly better thanks to a strong set of acquisitions. 

Well Health growth continues

Well Health Technologies provides telehealth and outpatient services in Canada and the United States. Founded in 2010, the company has experienced strong growth and quickly become a leading player in the health industry. It has grown both organically and through acquisitions. 

Are you looking for fast-news, hot-tips and market analysis? Sign-up for the Invezz newsletter, today.

The most recent acquisition happened in June when the company bought INLIV, an omnichannel provider of primary care, consumer preventative, and corporate healthcare. It paid over $1.6 million for the purchase.

While the Well Health Technologies stock price has dropped this year, recent results show that the company is doing well. Its revenue surged to $302 million in the year to December compared to the $50.2 million it made in the previous year. Its virtual services revenue rose to $75.6 million, a 450% growth from the previous year.

Is Well a good buy?

Analysts expect that the company will experience similar or even better growth in 2022. That’s because, unlike Teladoc that focuses purely on telehealth, Well has a strong presence in outpatient and primary care. At the same time, its recent acquisitions will help accelerate this growth.

Meanwhile, the company is accelerating its ESG credentials, which could see it attract more demand from ESG-focused funds. It recently published its first report on ESG. While ESG commitments can be vague often, the company seems committed to making its goals a reality. In a statement, the CEO said:

“We are proud to introduce our inaugural ESG Report that showcases our commitments, efforts, and responsibilities to drive real positive societal change for all of our stakeholders.”

Another catalyst for Well is the management’s focus to become profitable after spending the past few years on acquisitions. In its most recent earnings call, the management said that they expect the company to be profitable in 2022. If the management is correct, it will be a significant milestone for the firm as many telehealth firms lack a clear path to profitability in the coming years.

Well Health stock price forecast

The ongoing sell-off in global equities will present an opportunity to scoop quality stocks. Well could be one of them. On the chart below, we see that the shares have been in a strong bearish trend in the past few months. 

The stock managed to move below the important support at $3.77, which was the lowest point in January. It remains below the 25-day and 50-day moving averages while the Relative Strength Index is at the neutral point at 50. Therefore, there is a likelihood that the shares will bounce back in the coming months as investors attempt to retest the key resistance at $5.

Where to buy right now

To invest simply and easily, users need a low-fee broker with a track record of reliability. The following brokers are highly rated, recognised worldwide, and safe to use:

  1. Etoro, trusted by over 13m users worldwide. Register here >
  2. Capital.com, simple, easy to use and regulated. Register here >

*Cryptoasset investing is unregulated in some EU countries and the UK. No consumer protection. Your capital is at risk.

Related markets

 
TSE:WELL WELL Health Technologies Corp.
Price:
3.07
% CHG:
-4.06
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stocks & Shares
Newsletter
 
 
 
 
 

Aston Martin share price collapses to a new low. Buy the dip?

By: Crispus Nyaga
on Jun 30, 2022

The Aston Martin (LON: AML) share price continued its bearish trend on Thursday as demand for the stock waned. The stock dropped to an all-time low of 434p, which was over $97% below the all-time high. Its market cap has dropped to about £504 million, which is significantly lower than when it went public.

Why is AML collapsing?

Aston Martin Lagonda is one of the most iconic auto brands globally. The company manufactures some of the most iconic cars like Vantage, DBS, DB11, Valkyrie, and DBS. Its vehicles sell for millions of pounds and are well-known for their presence in James Bond movies.

Are you looking for fast-news, hot-tips and market analysis? Sign-up for the Invezz newsletter, today.

 

Aston Martin shares have had a difficult period even as demand for its vehicles remains substantially high. The stock has lost almost 100% of its value as the company has kept losing talent. It has lost several CEOs in the past few years.

Aston Martin has diverged from other luxury car brands like Ferrari. Ferrari, the famed Italian car company, is now valued at more than $30 billion as its stock has doubled in the past five years, 

The company is even struggling in Formula 1, where its drivers like Sebastian Vettel and Lance Stroll are all in the bottom ten. The two have accumulated just 16 points combined, The team ranks at position eight out of ten.

Aston Martin share price drop is worse than other automakers like Tesla, BMW, Toyota, and Ferrari. All these stocks have retreated as investors anticipate margin compression. 

The company’s growth has slowed dramatically. In its most recent quarterly results, the firm said that it expects that its volume will increase by just 8% this year. It expects to sell about 6,600 car units.

Still, there are two potential catalysts that could push the stock higher. First, the firm has a new CEO from Ferrari. There is a possibility that the new leader will accelerate the company’s turnaround. 

Second, the depreciating share price could make the firm a viable acquisition target, especially by private equity firms. The idea is that it is easier to change it as a private company.

Aston Martin share price forecast

Aston Martin share price

The daily chart shows that the AML stock price has been in a strong bearish trend in the past few months. The decline culminated with the stock’s drop below the important support at 707p, which was the lower line of the descending triangle pattern. 

The stock has also moved below the 25-day and 50-day moving averages while the RSI has moved below the oversold level.

Therefore, there is a likelihood that the shares will continue falling for a while before it makes a recovery in the next few months.

Where to buy right now

To invest simply and easily, users need a low-fee broker with a track record of reliability. The following brokers are highly rated, recognised worldwide, and safe to use:

  1. Etoro, trusted by over 13m users worldwide. Register here >
  2. Capital.com, simple, easy to use and regulated. Register here >

*Cryptoasset investing is unregulated in some EU countries and the UK. No consumer protection. Your capital is at risk.

Related markets

 
LON:AML Aston Martin Lagonda Global Holdings PLC
Price:
4.802
% CHG:
-9.80
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stocks & Shares
Newsletter
 
 
 

Former CEA Chair explains how to fight inflation right now


Comment by starboy101 on Jul 03, 2022 5:15pm
"Well Health Technologies (TSX: WELL) has outperformed other telehealth companies in the telehealth industry in 2020. While competitors like Doximity, Hims & Hers, and Teladoc have been hit badly, Well has fared significantly better thanks to a strong set of acquisitions." Wow talk about putting lipstick on a pig! Interesting to me that this article seems to have been published on ...more  
Comment by starboy101 on Jul 03, 2022 5:19pm
Correction to my previous post - " Wow talk about putting lipstick on a pig! Interesting to me that this article seems to have been published on June 30, 2020." Should be June 30, 2022.
Comment by starboy101 on Jul 17, 2022 4:15pm
Answer me Speedy! Again I ask you - Did the company compensate the author of this report or the publisher in any way? I await yoy reply!
Comment by speedy99 on Jul 18, 2022 8:01am
Why ask me.  Ask the author yourself.   Crispus Nyaga (@CrispusNyaga) / Twitter How would I know?  Just because I repost an article does not mean I endorse the position contained therein.  I posted the second Short Report on WELL several months ago because I like to see what people are saying about WELL, good or bad.  In another post he ...more